March 2025

🇺🇸🧪 BILL GATES VISITS INDIA (HIS LABORATORY) AGAIN

Bill Gates is currently in India, pushing his controversial mass vaccination agenda and health strategies that prioritise corporate profits over the well-being of the people.

His so-called "solutions" are raising serious questions about their true impact on India.

👇 Here’s a deep dive into his most controversial moves in India:

▪️ Polio vaccines: Bill Gates and the Gates Foundation were all-in on India’s polio eradication, but their push for the oral polio vaccine (OPV) may have caused more harm than good. The use of the vaccine have caused a rise in non-polio acute flaccid paralysis (NPAFP) as a side effect. Coupled with a top-down approach that ignored local needs, Gates' campaign seemed more about testing vaccines than addressing the real concerns of the people.

▪️HPV vaccines: In 2009, several schools for tribal children in Andhra Pradesh and Gujarat became Bill Gates' "labs" for human papilloma virus (HPV) vaccination. Thousands of girls aged 10-14 were vaccinated, but months later, many fell ill, and seven died by 2010. The regulatory agency found that consent was often obtained from hostel wardens, violating ethical norms.

▪️Cow vaccines: Bill Gates thought it was a good idea to fund cattle vaccines in India, completely ignoring that cows are sacred to many Hindus. While claiming to improve livestock health, Gates pushed for methane-reducing vaccines. The program faced backlash from cow protection groups, which advocated for the protection of the animal.

▪️Bill Gates claims India as a laboratory: In a 2010 interview, Gates referred to India as a "laboratory" for testing his health initiatives, which many saw as a condescending view, treating India’s poor as mere subjects for experimentation rather than respecting the country's sovereignty in health matters.

▪️ GMO seeds: Gates' support for Bt Cotton in India, introduced in the early 2000s, sparked controversy over seed monopolies, environmental risks, and high costs. Farmers criticised the lack of support and education about their use, with some linking the technology to farmer suicides due to debt and crop failures. Current updates

February 2026

Free HPV vaccination programmes for adolescent girls

The center is to roll out a national-wide Human Papilloma virus (HPV) free Vaccination Programme for adolescent girls aged 14 years, in a push to prevent cervical cancer.

The vaccination will be voluntary and administered free of cost at the designated government health facilities, including Ayushman Arogya Mandir, community and district hospitals, and government medical colleges.

India will join more than 160 countries that have already introduced HPV vaccinations. This is supported through a mechanism under India's partnership with GAVI, the Vaccine Alliance, ensuring quality assured vaccines that meet regulatory and cold chain standards

This follows a scientific evaluation and recommendations of the National Technical Advisory Group on Humanisation (NTAGI). The India's program will use the quadrivalent HPV vaccine Gardasil, which protects against HPV type 16 and 18, linked to cervical cancer, as well as types 6 and 11.

Cervical cancer is the most common cancer among women in India, with around 80,000 new cases and more than 42,000 deaths recorded every year, which is more than 50% of the cases added.

Persistent infection with high-risk HPV strains, particularly type 16 and 18, accounts for over 80% of the cervical cancer cases in the country.

HPV vaccines have a strong global safety and efficacy record, with over 500 million doses administered worldwide since 2006. Evidence shows that the vaccine is 93-100% effective in preventing cervical cancer.

Vaccinating girls at the recommended age, before exposure to the virus, reduces the long-term burden of cervical cancer.

The HPV virus is transmitted through close skin-to-skin contact. Most HPV infections result on their own. Persistent infection with certain high-risk types, especially 16 and 18, can lead to cervical cancer over time.

Vaccinating girls at the age of 14 ensures protection well before potential infection, leading to a long-lasting immunity and a significant reduction in future cervical cancer risks. Studies show strong and durable protection when the vaccine is administered in this age group.

Strategic Advisory Group of Experts on Immunization evaluated the evidence that has been emerging over the past years that single-dose schedules provide comparable efficacy to two- or three-dose regimens. The review concluded that single-dose human papillomavirus vaccine provides adequate protection against HPV that is comparable to two-dose schedules.

WHO Position Paper on HPV Vaccine, dated December 2022: A single-dose schedule can be used in girls and boys aged 9 to 20 years. Current evidence suggests that a single-dose schedule has comparable efficacy and duration of protection as a two-dose schedule and may offer program advantages, be more efficient and affordable. A minimum of two doses and, when feasible, three doses are necessary for those known to be immunocompromised and/or HIV infected. NDTV